Antia Laboratories Inc.

New products

No new product at this time



Please contact us for quotation and availability

CAS No.: 87679-37-6

Molecular Formula: C24H34N2O5

Molecular Weight: 430.54

Systematic name: (2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid (non-preferred name)

Trandolapril is a newer angiotensin-converting enzyme (ACE) inhibitor that is approved by the US Food and Drug Administration for the treatment of hypertension and for use in stable patients who have evidence of left ventricular (LV) systolic dysfunction or symptoms of chronic heart failure within the first 2 days after an acute myocardial infarction (AMI).


1. David R.F. Guay, et al: Clinical Therapeutics, Volume 25, Issue 3, March 2003, Pages 713-775 "Trandolapril: A newer angiotensin-converting enzyme inhibitor" Full text

The product is only for R&D purpose,not for human use.We will not take any responsibility for illegal use.